Biomarker Tool for Pre-Clinical Research into kidney Function

Invitrogen announced the global availability of a new biomarker tool for use in pre-clinical research into kidney function. The PlexMark™ 3 Renal Biomarker Panel Assay is a non-invasive and cost-effective research tool for performing post-transplantation kidney function studies rapidly and easily. The introduction of this research tool is expected to help in the development of studies, which may lead to more effective methods for monitoring
kidney health in transplant research.

This new assay provides researchers with an alternative to invasive and expensive procedures, such as biopsies, used to obtain kidney tissue samples to allow research into posttransplantation kidney function. The PlexMark 3 Renal Biomarker Panel Assay measures levels of cytokines, chemokines and receptor levels in urine, which give researchers a better understanding of immune function and response. This may lead to the development of new, non-invasive tests to monitor kidney function and health following transplant procedures.

The PlexMark assay uses Luminex® xMAP® multiplexing technology for bioassay analysis, in a standard immunoassay format to offer ease-of-use, sensitivity and rapid, reproducible results. The biomarkers in the PlexMark panel are licensed from Renovar Inc, a pioneer in the development of new tools for assessing kidney inflammation for numerous clinical indications.